Abstract
The non-isotopic in situ hybridization makes it possible the analysis of, both, numeric and structural chromosome aberrations in interphase nuclei. Moreover, this technique is useful for identification of chromosome markers of unknown origin, frequently present in malignant diseases. In our case, the fluorescent in situ hybridization allowed us, in a CML patient in accelerated phase, to know the origin of a chromosome marker, and then, to state that the patient had a 21 trisomy added to the Philadelphia chromosome.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Blast Crisis / pathology
-
Chromosomes, Human, Pair 18 / ultrastructure
-
Chromosomes, Human, Pair 21*
-
DNA Probes
-
Gene Library*
-
Genetic Markers*
-
Humans
-
In Situ Hybridization, Fluorescence*
-
Interphase
-
Karyotyping
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
-
Leukemia, Myeloid, Accelerated Phase / genetics
-
Leukemia, Myeloid, Accelerated Phase / pathology*
-
Male
-
Middle Aged
-
Philadelphia Chromosome
-
Translocation, Genetic
-
Trisomy*
Substances
-
DNA Probes
-
Genetic Markers